Hover a dot or row, or tab through the dots · bars scaled to the largest round ($109M)
Form D offerings
One line per offering, amendments folded in, newest first
Form D offerings
File
First filed
Latest
Sought
Sold
Investors
Exemptions
021-435400
First filed2022-03-01
Latest2022-03-01
Sought$156M
Sold$109M
Investors45
Exemptions506(b)
021-339588
First filed2019-05-14
Latest2019-05-14
Sought$134M
Sold$101M
Investors101
Exemptions506(b)
021-303642
First filed2018-01-19
Latest2018-01-19
Sought$15M
Sold$9.5M
Investors21
Exemptions506(b)
021-250709
First filed2015-11-05
Latest2015-11-05
Sought$16M
Sold$16M
Investors30
Exemptions506(b)
Who backs Visby Medical, Inc., inferred from co-filings, and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2022-03-01
Related persons
Name
Relationship
Adam de la Zerda
RelationshipExecutive Officer, Director
Mark Ibison
RelationshipExecutive Officer
John Kuo
RelationshipExecutive Officer
Jerome Behar
RelationshipDirector
Terri Bresenham
RelationshipDirector
Shlomo Melmed
RelationshipDirector
Scott E. Mendel
RelationshipDirector
Eric Moessinger
RelationshipDirector
Thomas M. Prescott
RelationshipDirector
Amit Shah
RelationshipDirector
Facts
As its latest Form D states them
Industry
Other Health Care
State
California (CA)
Exemptions
Rule 506(b)
First filed
2015-11-05
Latest filing
2022-03-01
Who backs Visby Medical, Inc.
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
Inferred investors — the funds and firms behind it, from co-filings and shared people
Every Form D and amendment as filed, with what each one stated
Its rounds in sequence: the gap between them and whether they grew
Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)